Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

NCT02944201 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Carvedilol

Sponsor

Montefiore Medical Center

Collaborators

[object Object]